Jay Roberts

Jay Roberts is a seasoned executive in the healthcare industry with over 30 years of experience.12 He was recently appointed as a Member of the Board of Directors at Cingulate Inc., a biopharmaceutical company focused on developing next-generation pharmaceutical products using their proprietary Precision Timed Release™ (PTR™) drug delivery platform technology.1

Professional Background

Jay Roberts has held several high-level positions throughout his career, including:

• CEO, COO, and CFO roles in publicly traded and venture/private equity-backed healthcare technology companies1
• Venture Partner for DigiLife Fund II, where he leads fundraising, due diligence, and investment decisions1
• Board member for multiple companies, including Caidya, Inc., Veriskin, Inc., NaviPoint Health, Inc., and Vyant Bio, Inc.12
• President and CEO of Vyant Bio from April 2018 to February 20232
• Executive Board Member of Fight Cancer Global2
• Member of the Board of Directors for the Drug Information Association2

Education and Expertise

Jay Roberts' expertise spans various areas within the healthcare industry, including:

• Healthcare technology
• Diagnostics
• Software solutions
• Manufacturing

His educational background includes studies at the University of Maine.2

Current Role at Cingulate Inc.

As a newly appointed Board Member at Cingulate Inc., Jay Roberts is expected to contribute his extensive experience in business, public markets, finance, healthcare, and pharmaceuticals to help guide the company's clinical trials and business opportunities.1

Jay Roberts' appointment to Cingulate's Board of Directors, along with Bryan Lawrence and Jeff Ervin, follows the company's recent successful capital-raising activities, including a $7.5 million follow-on offering and $3.2 million in sales under their at-the-market offering facility.1